aTyr Pharma (LIFE) Gains on Orphan Drug Designation

aTyr Pharma Inc (NASDAQ: LIFE) rose 2.8% to $3.65 after the company disclosed that it has received the EMA orphan drug designation for resolaris. Share volume was 109,000, compared to an all-day average of 291,000